We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Halts Phase 3 Trial of Tominersen for Huntington’s Disease
Roche Halts Phase 3 Trial of Tominersen for Huntington’s Disease
Roche is stopping its phase 3 trial of tominersen, its investigational drug to treat Huntington’s disease, a rare neurodegenerative condition for which there is no known cure.